Home > Newsletters > Drug Industry Daily > No Reprieve for Pharma as Third Circuit Refuses to Stay K-Dur Anti Pay-for-Delay Ruling
Drug Industry Daily
Aug. 21, 2012 | Vol. 11 No. 164
No Reprieve for Pharma as Third Circuit Refuses to Stay K-Dur Anti Pay-for-Delay Ruling
Drugmakers operating in the Third Circuit Court of Appeals jurisdiction will need to remain cautious about engaging in reverse patent settlements as the court refused to put on hold its recent ruling that such deals are anticompetitive while Merck and Upsher-Smith appeal to the Supreme Court.
ePublishing :: CMS, Hosting & Web Development | © Copyright by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.